| Literature DB >> 208804 |
K Yamamoto, S Koga, H Ibayashi.
Abstract
The apolipoprotein A-1 in cholestatic liver diseases was determined by rocket immunoelectrophoresis. A decrease in the serum apo A-1 was generally observed in LP-X positive liver disease, particularly in the patients with extrahepatic biliary obstruction. With reference to LP-X levels and LCAT activity, the results indicated that not only hepatocellular damage but also cholestasis contribute to the decrease of apo A-1 concentration in patients with liver disease.Entities:
Mesh：
Substances：
Year: 1978 PMID： 208804 DOI： 10.1016/0009-8981(78)90061-x
Source DB: PubMed Journal: Clin Chim Acta ISSN： 0009-8981 Impact factor: 3.786